Stock listing

NASDAQ:INTS Intensity Therapeutics, Inc. Stock

Home listing (NASDAQ) of Intensity Therapeutics, Inc.

Follow Intensity Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:INTS

$2.48 USD -0.16 (-6.1%)

Close on Nov 20, 2026

Past year -73.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$2.28 – $2.48 USDNov 20, 2026
Volume
62,413 sharesNov 20, 2026
Market cap
$8.19M USDAt the close on Nov 20, 2026 · price × 3.30M shares outstanding
52-week range
$2.28 – $15.00 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$87,908 USDMedian day 14,700 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Intensity Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:INTS · Home$2.48 USD-0.16 (-6.1%)62,413$2.385$2.48$2.28$2.64Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:INTS · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$2.48-0.16-6.1%$2.385$2.48$2.2862,413
$2.64-0.03-1.1%$2.67$2.82$2.52621,052
$2.67-0.40-13.0%$2.92$2.965$2.5922,537
$3.07-0.01-0.3%$3.08$3.08$3.004,548
$3.08-0.02-0.6%$3.06$3.09$2.9225,623
$3.10-0.18-5.5%$3.25$3.341$3.1011,012
$3.28+0.19+6.1%$3.163$3.39$3.1636,587
$3.09-0.06-1.9%$2.972$3.26$2.9728,653
$3.15+0.15+5.0%$2.94$3.25$2.8056,621
$3.00-0.10-3.2%$3.01$3.19$2.91515,416
$3.10-0.40-11.4%$3.16$3.32$2.8050,149
$3.50+0.12+3.6%$3.30$3.576$3.306,709
$3.38-0.05-1.5%$3.23$3.40$3.195,790
$3.43+0.03+0.9%$3.41$3.47$3.2315,576
$3.40+0.06+1.8%$3.40$3.455$3.2116,111
$3.34-0.04-1.2%$3.39$3.43$3.147,648
$3.38+0.20+6.3%$3.28$3.38$3.281,366
$3.18-0.02-0.6%$3.13$3.195$3.1015,283
$3.20-0.05-1.5%$3.20$3.24$3.0010,272
$3.25+0.06+1.9%$3.14$3.31$3.146,412
$3.19+0.047+1.5%$3.22$3.509$3.096,838
$3.143-0.137-4.2%$3.25$3.51$3.139,846
$3.28-0.01-0.3%$3.31$3.31$3.252,592
$3.29-0.06-1.8%$3.21$3.295$3.157,192
$3.35-0.03-0.9%$3.40$3.40$3.1432,300
$3.38-0.04-1.2%$3.35$3.55$3.358,300
$3.42-0.13-3.7%$3.56$3.58$3.29325,900
$3.55+0.24+7.3%$3.20$4.04$3.097123,700
$3.31-0.32-8.8%$3.70$3.70$3.1442,000
$3.63-0.05-1.4%$3.75$3.75$3.5516,700
$3.68-0.12-3.2%$3.76$3.80$3.5819,200
$3.80+0.25+7.0%$3.47$3.87$3.46317,200
$3.55+0.10+2.9%$3.34$3.67$3.347,500
$3.45+0.01+0.3%$3.45$3.75$3.4528,800
$3.44+0.23+7.2%$3.27$3.45$3.2115,400
$3.21-0.16-4.7%$3.36$3.563$3.2115,300
$3.37-0.05-1.5%$3.40$3.457$3.27520,900
$3.42-0.23-6.3%$3.70$3.70$3.2734,000
$3.65-0.15-3.9%$3.90$3.90$3.6336,200
$3.80-0.09-2.3%$4.096$4.096$3.808,400
$3.89-0.21-5.1%$4.18$4.18$3.8910,600
$4.10+0.09+2.2%$3.98$4.10$3.984,100
$4.01-0.01-0.2%$4.01$4.11$3.88814,700
$4.02-0.09-2.2%$4.24$4.30$4.026,400
$4.11+0.23+5.9%$3.79$4.29$3.7945,100
$3.88+0.07+1.8%$3.989$3.989$3.798,300
$3.810.000.0%$3.821$3.93$3.758,300
$3.81-0.17-4.3%$3.95$3.98$3.813,900
$3.98-0.04-1.0%$3.959$4.053$3.9037,200
$4.02-0.02-0.5%$4.10$4.118$3.9810,500
$4.04+0.02+0.5%$4.04$4.06$4.042,300
$4.02-0.07-1.7%$4.12$4.12$3.996,000
$4.09-0.01-0.2%$4.07$4.13$4.0611,600
$4.10+0.10+2.5%$3.99$4.11$3.994,500
$4.000.000.0%$4.12$4.12$4.0010,000
$4.00-0.07-1.7%$4.10$4.146$4.0014,200
$4.07-0.14-3.3%$4.18$4.18$4.0223,700
$4.21-0.04-0.9%$4.271$4.28$4.206,400
$4.25-0.02-0.5%$4.30$4.579$4.2222,400
$4.27-0.26-5.7%$4.59$4.70$4.1975,200
$4.53-0.365-7.5%$4.83$5.075$4.36126,300
$4.895+0.145+3.1%$4.71$5.17$4.695103,893
$4.75-0.11-2.3%$4.57$4.86$4.5726,899
$4.86-0.02-0.4%$4.89$4.89$4.53120,200
$4.88+0.68+16.2%$4.16$4.91$4.1668,800

Splits

1 split · NASDAQ:INTS · every price before a split is adjusted for it

DayRatioWhat
1-for-25Consolidation
Ticker
NASDAQ:INTS
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Intensity Therapeutics (NASDAQ:INTS) Q3 2026 Earnings Call

    Thu, Nov 05, 2026 · 8:00 AM ET

    Watch Transcript
  • Intensity Therapeutics (NASDAQ:INTS) Q2 2026 Earnings Call

    Tue, Aug 11, 2026 · 8:00 AM ET

    Watch Transcript
  • Intensity Therapeutics (NASDAQ:INTS) Q2 2023 Earnings Call

    Mon, Aug 14, 2023 · 8:00 AM ET

    Watch Transcript

Latest news

All Intensity Therapeutics, Inc. news

Financings

  • Registered direct offering of shares of common stock

    Oct 31, 2025

    Announced: about US$4M · US$0.8 a share · A.G.P./Alliance Global Partners

    Dealers: A.G.P./Alliance Global Partners (lead)

    Buyers: new long-term fundamental investor (5,000,000 shares of common stock)

    Use of proceeds: Advancing clinical trials, working capital and general corporate purposes

    Announced Oct 31, 2025

  • At-the-market programme of shares of common stock

    Aug 4, 2025

    Tranche closed: US$6.6M raised · US$0.3323 a share

    Use of proceeds: Strengthen the balance sheet and continue advancing clinical trials into the second half of 2026

    Tranche closed Aug 4, 2025

  • Public offering of shares of common stock

    Jun 12, 2025

    Announced: US$2M · US$0.3 a share · ThinkEquity

    Dealers: ThinkEquity (lead)

    Use of proceeds: Enrolling patients and reaching data read out in INVINCIBLE-4, treating existing INVINCIBLE-3 patients, working capital and general corporate purposes

    Announced Jun 11, 2025 · Announced Jun 12, 2025

  • Public offering of shares of common stock (or common stock equivalents) with Series B-1 and Series B-2 common warrants

    Apr 25, 2025

    Announced: about US$2.35M · US$0.75 a share · Warrants at US$0.85 for 60 months · A.G.P./Alliance Global Partners +1

    Dealers: A.G.P./Alliance Global Partners (lead), Brookline Capital Markets, a division of Arcadia Securities, LLC

    Use of proceeds: Enrolling patients in the INVINCIBLE-4 Study, treating existing INVINCIBLE-3 patients, working capital and general corporate purposes

    Announced Apr 25, 2025

Read by 6ix AI from the company's releases

Decks

Intensity Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
19 in the last 12 months · 74 in all · newest Nov 5, 2026 · oldest 2022
Calls
3 calls with a replay · 3 with a transcript · latest Nov 5, 2026
Decks
15 decks · latest Jun 11, 2025

Where Intensity Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:INTS · Home listing · This pageNASDAQUnited StatesUSD
BOATS:INTSBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Intensity Therapeutics, Inc.